Cattie Christopher T 4
4 · QNB CORP. · Filed Feb 13, 2026
Research Summary
AI-generated summary of this filing
QNB CORP. COO Christopher T. Cattie Exercises Options
What Happened
Christopher T. Cattie, Chief Operating Officer of QNB CORP. (QNBC), exercised stock options to acquire 3,375 shares with an exercise price of $32.50 (total exercise cost $109,688). To satisfy tax withholding obligations, 2,933 of the issued shares were withheld/disposed at a reported value of $37.63 per share (total ~$110,369). Net result: Cattie retained 442 shares (3,375 exercised − 2,933 withheld).
Key Details
- Transaction date: February 12, 2026; Form 4 filed February 13, 2026 (timely).
- Option exercise: 3,375 shares @ $32.50 = $109,688 (code M).
- Tax withholding/disposition: 2,933 shares @ $37.63 = $110,369 (code F).
- Derivative/option reporting: a corresponding derivative entry shows the options converted/settled (reported as disposed).
- Shares owned after transaction: not specified in the provided data; net new shares retained from this event = 442.
- No 10b5-1 plan or other footnotes were provided in the supplied details.
Context
This was an option exercise with shares withheld to cover tax liabilities (a common, administrative transaction). The exercise resulted in a modest net increase in the executive’s holdings (442 shares). Exercises and withholding are routine insider filings and do not by themselves indicate the insider’s future view of the company.
Insider Transaction Report
- Exercise/Conversion
Common Stock
2026-02-12$32.50/sh+3,375$109,688→ 7,035.017 total - Tax Payment
Common Stock
2026-02-12$37.63/sh−2,933$110,369→ 4,102.017 total - Exercise/Conversion
Common Stock(Right to Buy)
2026-02-12$32.50/sh−3,375$109,688→ 0 totalExercise: $32.50From: 2024-02-15Exp: 2026-02-15→ Common Stock (3,375 underlying)
- 3,500
Common Stock(Right to Buy)
Exercise: $37.26From: 2025-02-15Exp: 2027-02-15→ Common Stock (3,500 underlying) - 700
Common Stock(Right to Buy)
Exercise: $29.51From: 2024-02-15Exp: 2033-02-15→ Common Stock (700 underlying) - 700
Common Stock(Right to Buy)
Exercise: $29.51From: 2025-02-15Exp: 2033-02-15→ Common Stock (700 underlying) - 700
Common Stock(Right to Buy)
Exercise: $29.51From: 2026-02-15Exp: 2033-02-15→ Common Stock (700 underlying) - 700
Common Stock(Right to Buy)
Exercise: $29.51From: 2027-02-15Exp: 2033-02-15→ Common Stock (700 underlying) - 700
Common Stock(Right to Buy)
Exercise: $29.51From: 2028-02-15Exp: 2033-02-15→ Common Stock (700 underlying) - 600
Common Stock(Right to Buy)
Exercise: $23.40From: 2025-02-15Exp: 2034-02-15→ Common Stock (600 underlying) - 600
Common Stock(Right to Buy)
Exercise: $23.40From: 2026-02-15Exp: 2034-02-15→ Common Stock (600 underlying) - 600
Common Stock(Right to Buy)
Exercise: $23.40From: 2027-02-15Exp: 2034-02-15→ Common Stock (600 underlying) - 600
Common Stock(Right to Buy)
Exercise: $23.40From: 2028-02-15Exp: 2034-02-15→ Common Stock (600 underlying) - 600
Common Stock(Right to Buy)
Exercise: $23.40From: 2029-02-15Exp: 2034-02-15→ Common Stock (600 underlying) - 860
Common Stock(Right to Buy)
Exercise: $33.50From: 2026-02-14Exp: 2035-02-14→ Common Stock (860 underlying) - 860
Common Stock(Right to Buy)
Exercise: $33.50From: 2027-02-14Exp: 2035-02-14→ Common Stock (860 underlying) - 860
Common Stock(Right to Buy)
Exercise: $33.50From: 2028-02-14Exp: 2035-02-14→ Common Stock (860 underlying) - 860
Common Stock(Right to Buy)
Exercise: $33.50From: 2029-02-14Exp: 2035-02-14→ Common Stock (860 underlying) - 860
Common Stock(Right to Buy)
Exercise: $33.50From: 2030-02-14Exp: 2035-02-14→ Common Stock (860 underlying)